ESPR - Momentum Biotech Play

已更新
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.


Disclaimer: This content is for informational purposes only and should not be considered financial advice.

Recent Activities:
May 22, 2024: First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and its combination with Ezetimibe, NUSTENDI® (NEXLIZET® in the U.S.), approved in Europe to treat hypercholesterolemia and significantly reduce cardiovascular risk.

Block and Insider Buys: A few notable transactions observed recently.

Trading Volume: Significant increase in trading volume.

Investment Snapshot (As of June 7, 2024):
Relative Volume: 1.82
Shares in Circulation: 154.69 million
Short Float: 16.10%

Key Technical Levels:
2.80 - 3.00 Zone: Highly important due to strong resistance levels. Conservative traders might want to wait for a break above this zone and closely watch price action thereafter.

Resistance Points:
$2.80 - $3.00: Initial resistance zone.
$3.30, $3.60, $3.80: Monitor these levels; surpassing them could indicate a positive trend. Taking profits at these stages may help in realizing gains.

Trading Strategy:
Take Profit (TP): Aim for a target profit of $3.50, with a possibility of reaching up to $4.50.
Stop Loss (SL): Establish a stop loss below $2.50 to mitigate potential losses.

Chart Analysis:
Refer to the attached chart for a detailed analysis of price trends and movements.

Trading Advisory:
Exercise caution and consider market conditions and your own risk tolerance when trading. It's advisable to conduct comprehensive research or consult with a financial advisor before engaging in trading activities.
注释
nice push to resi - zone - was good for a quick scalp

couldn't hold above 3.0

let's see what's going to happen next days.
Chart PatternsFundamental AnalysisTrend Analysis

免责声明